top of page

2016

Solas BioVentures to Seek Up to $100M for Second Early-Stage Fund

SEPT 2, 2016

Learn More

Drug Developer Arrivo BioVentures Launches With $49M 

MAY 25, 2016

Learn More

CardioNXT Secures Additional $1.5M Funding From Solas BioVentures To Drive Atrial Fibrillation Treatment Innovation

MAY 24, 2016

Learn More
New transparent.png
bottom of page